Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,914
Total Claims
$1.8M
Drug Cost
647
Beneficiaries
$2,782
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+161%
Cost per patient vs peers
$2,782 vs $1,068 avg
+91%
Brand preference vs peers
17.2% vs 9.0% avg
Brand vs Generic
Brand: 1,693 claims · $1.6M
Generic: 8,134 claims · $199K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 205 | $229K |
| Empagliflozin | 136 | $183K |
| Semaglutide | 128 | $182K |
| Apixaban | 117 | $106K |
| Tirzepatide | 74 | $100K |
| Fluticasone/Umeclidin/Vilanter | 83 | $82K |
| Finerenone | 63 | $64K |
| Empagliflozin/Linagliptin | 21 | $35K |
| Sacubitril/Valsartan | 19 | $33K |
| Umeclidinium Brm/Vilanterol Tr | 30 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 27 | $31K |
| Dulaglutide | 14 | $30K |
| Sitagliptin Phosphate | 24 | $30K |
| Dapaglifloz Propaned/Metformin | 19 | $28K |
| Linaclotide | 28 | $28K |
Prescribing Profile
Patient Profile
74
Avg Age
55%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data